drugset / Trial / NCT01256190

A Study of Fibrocaps in Liver Surgery in the Netherlands

NCT01256190

Phase 2 Completed 56 enrolled Mallinckrodt
RandomizedParallel-groupSingle-blindTreatment

Summary

A multi-center, prospective, randomized, single-blind, controlled, comparative efficacy and safety trial in subjects undergoing open liver resection surgery. The study will enroll 42 eligible subjects and be conducted at 4 sites in the Netherlands.

Timeline

Start
2010-12
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic Topical

Indications

No indication recorded.